Dorson and Larsen’s seminal work coincided with biomedical research by other scientists and practitioners around the country, particularly Robert Bartlett, a physician and medical researcher at the University of Michigan. He is an emeritus professor of surgery at the University of Michigan Medical School. Toggle navigation ; Home; Search; Services; Blog; Contact; About; Ecmo in Respiratory Failure Bartlett, Robert H. Nationwide/Regional Organization of ECMO for ARF d ECMO is a high-risk and complex therapy that may be considered for the sickest patients with ARF. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. Robert Bartlett, known as the father of ECMO, notes that the indication for the use of ECMO in COVID-19 is when a patient is in respiratory failure and not responding to mechanical ventilation. Extracorporeal membrane oxygenation (ECMO) allows the intensivist to manipulate determinants of oxygenation which are not possible during conventional mechanical ventilation. There are currently over 70,000 cases in the ELSO Registry. Recent advances in cannula and pump technology have made ECMO safer and more portable allowing for its deployment in a wider group of patients. Earlier trials with ECMO support demonstrated improved survival in infants with severe,. Hsieh Forbes Column: "Dr. {Robert H. Currently a Professor of Surgery in the Division of Acute Care Surgery at the University of Michigan Medical Center and the. In the late 1960s, Drinker developed the device with Dr. . The aim of this review is to summarize contemporary data describing the clinical and logistical considerations required to institute a VA-ECMO program with successful clinical outcomes in the context of four key themes that pertain to VA- ECMO programs: the principles of patient selection; basic hemodynamic and technical principles. The 1990s group were on ECMO for shorter duration, median of 131 h (interquartile range. D. An RCT in the 1970s had shown ECMO not effective for ARDS in adults In the 1980s, Robert Bartlett used ECMO to treat newborns with PPHN Results were very impressive But, pediatricians were reluctant to adopt ECMO without convincing data from an RCTBartlett, Robert H. In pediatric populations, ECMO is used for organ support in cases of respiratory failure, cardiac failure, and as an adjunct to cardiopulmonary resuscitation (E-CPR) during cardiac arrest [3–6]. Joseph A. 4 Modern ECMOs roots, however, are in neonatal critical care whereby Dr Robert Bartlett pioneered its use in pediatric cardiopulmonary failure and published the first randomized controlled trial comparing ECMO. 1097/MAT. Abstract. A comparative Trial of ECMO for Neonatal Respiratory Failure in the Netherlands. 40 Division of Pulmonary, Allergy, and Critical Care, Columbia University College of Physicians and Surgeons/NewYork-Presbyterian Hospital, 622 W168th St, PH 8E, Room 101, New York, NY, 10032, USA. He is often called the “ Father of. PMID: 29084039 DOI: 10. “ECMO, like conventional mechanical ventilation, doesn't treat COVID-19, but it keeps the patient alive while the disease runs its course. The baby‘s mother—a poor, illiterate woman from Baja, Mexico—crossed the border and headed for. Awad, MD; Stefania Crotti, MD; Ronald B. Robert Bartlett, one of ECMO's developers. Design Observational study. Lexington, SC 29072. Neonatal ECMO survival to discharge decreased over the two time periods (76 vs 67%, p < 0. The first successful use of ECMO in an adult was reported by Robert Bartlett in 1971. History of ECMO. Robert Bartlett: Passato, presente e futuro dell'ECMO. Robert Bartlett helped pioneer technology that takes over the heart and lung functions of an exhausted patient, allowing them more time to recover. Bartlett. An overview article in Lancet Respiratory Medicine examines the role of ECMO and ECMO centers during the COVID-19 pandemic. Robert Bartlett, at the University of Michigan (who also conducted research earlier at the University of California, Irvine), is widely regarded as the founding father of ECMO. CO 2 removal is much more efficient than oxygena-The first successful use of ECMO in the ICU was reported in a 24-year-old trauma patient who was cannulated due to posttraumatic ARDS. . Earlier trials with ECMO support demonstrated improved survival in infantsThe use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, although there is controversy regarding the evidence justifying its use (1–9). Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Three years later, the child was reported to be well, “with no cardiac, neurologic, or renal problems”23. He developed this technique when he was at the University of California Irvine and spent the majority of his career at University of Michigan in Ann Arbor perfecting its use. The first successful neonatal ECMO was performed by Dr. Physiology of gas exchange during ECMO for. Bartlett, MD, who is credited with developing extracorporeal membrane oxygenation (ECMO) in the 1960s and ’70s. the ELSO registry between Jan 16 and May 1, 2020, were included in the analysis. 1. Many clinicians were then enthused by the technology and o ered it to their patients. โรเบิร์ต บาร์ทเลตต์: บิดาผู้คิดค้นเครื่อง ECMO ช่วยชีวิตคนทั้งโลกให้รอดจากภาวะหัวใจและปอดล้มเหลว . 22. White was making progress using VV ECMO in infants with respiratory. Rycus and John F. 28,271 of these cases are newborn infants with respiratory failure [2]. The primary faculty members supporting the lab are Dr. (venoarterial [VA] ECMO) or a vein (venovenous [VV] ECMO). Dr. Bartlett: Logistical considerations for establishing an ECMO program. doi: 10. โรเบิร์ต บาร์ทเลตต์ (Robert Bartlett). Bartlett for the use of this guide on our website. Methods We presented three neonates with PPHN supported by ECMO in our center. Real-time trigger alerts. The primary outcome was in-hospital death in a time-to-event analysis assessed at 90 days after ECMO initiation. Search 69 grants from Robert Bartlett Search grants from University of Michigan Ann Arbor. Mechanical cardiopulmonary support goes by many names under the general heading of extracorporeal life support. Robert H. . Our first patient was in 1981, with a total of eight patients that year. The recent experience in 2009 using ECMO for pandemic influenza A(H1N1)–associated acute respiratory distress. P. Robert H. This guideline describes prolonged extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO), applicable to Pediatric respiratory failure. 2020-2023. Robert H. Vascular access can be obtained using the Crescent™ Dual Lumen Catheter. More From Forbes. DOI: 10. Robert Bartlett , professor emeritus of surgery. H. 2021 Aug 10;. 🎂 Wishing the Father of #ECMO Dr robert bartlett a great birthday today!ECMO: The medical innovation you probably never heard of that has saved thousands of babies (and adults). . The use of Novalung as an ECMO device for critical care has several benefits. Ecmo: past, present and future. I consider this landmark article to be a tribute to the career of Robert H. Griffith, MD, from the University of Pittsburgh, visited Dr. INTRODUCTION. Toggle navigation ; Home; Search; Services; Blog; Contact; About; Ecmo in Respiratory Failure Bartlett, Robert H. All ECMO patients should be included in a mobilisation protocol unless there are contraindications, which include hypoxia, hemodynamic instability, unstable cardiac rhythm, intracranial pressure monitoring, lose or unstable cannula sites, desaturation episodes with minimal movements, escalation of vasopressors in the last 12 h, and. Nel 1974, fu condotto uno. Lorenzo Berra, Warren M. Walton Lillehei. M. Bartlett. Bartlett, Gail M. As I reread this article today, I am struck by issues of time warp. The original MC3 was founded in 1991 by Robert Bartlett. columbia. Two were in England, namely the University of Leicester and the University of London. 3 days with ECMO. CA, Robert Bartlett and Alan Gazzaniga utilised partial VA ECMO to support a two-year-old boy with cardiogenic shock following a Mustard procedure for transposition of the great vessels22. Bartlett to the University of Michigan. Bartlett, ASAIO Journal, 2016 Mar-Apr; 62(2):. Compr Physiol 10 : 2020, 879–891. Carotid arterial access scares people, but it is safer than femoral arterial cannulation (personal communication with Dr. How ECMO Saved Baby Esperanza. by Julian Walling. While in the past ECMO was associated with poor outcomes and high complication rates, technical advances coupled with accumulating. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. Dr. ECMO Fellowship, Robert Bartlett MD Research Lab University of Michigan, Ann Arbor. of treatment. Robert Bartlett Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) has been successful in support of neonates with respiratory failure but requires right common carotid artery ligation. Bartlett, MD. Correspondence to robbar@umich. World's Largest ECMO Patient Registry and Largest Community of ECMO Centers. Robert Bartlett helped save her life as a newborn. Join Michigan Medicine ECMO Specialists and Robert Bartlett, M. Bartlett is the senior investigator within the laboratory. Robert Bartlett. Patients were also transported on ECMO from our ECMO center to other centers due to shortage of available ECMO beds. , D. ECMO may be used clinically in selected cases to provide life support when all other modes of therapy have been exhausted and Survival of moribund patients has been demonstrated. 1). Dr. Disclaimer: ECMO has, and will certainly continue, to play a role in the management of COVID-19 patients. Bartlett continues to direct the ECLS laboratory as it investigates new patient populations and clinical applications. Johnny Gray posted images on LinkedIn. Robert H Bartlett, ECMO Laboratory, B560 MSRB II, 1150 W Medical Center Drive, Ann Arbor; MI 48109, USA. 1997; 25 (1):28–32. Currently we average 100+ patients per year. 29 patients (15 neonates, seven pediatric, and seven adult patients) with acute. They discuss the evolu…Robert Bartlett Background: The high-quality evidence on managing COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support is insufficient. Abbreviation used is: ECMO, extracorporeal mem-brane oxygenation. Over the past 40 years, the need for ECMO in neonates has decreased due to advances in critical. We describe our experience of 30 consecutive children supported with ECMO and receiving 20 ppm of nitric oxide in the oxygenator of the ECMO circuit. PDF. B. Significantly less flow was required during Femoro-Atrial VV ECMO A Prospective Comparison of Atrio-Femoral and Femoro- Atrial Flow in Adult Venovenous Extracorporeal Life Support Preston B. Bartlett successfully treated the first newborn in 1975 in Irvine, California. Yamaan Saadeh . Hannah Abraham, die gerade ihren MD- und PhD-Abschluss in Michigan erhalten hatte. The ECLS Lab is a collective of several faculty members. It is simply amazing to remember that during the time Bartlett was providing ECMO for these reported patients, much of critical care medicine was in its infancy. Bartlett from the University of California, Irvine, to the University of Michigan, where experience gradually. La prima esperienza positiva di assistenza respiratoria nell’adulto è stata descritta da Hill nel 1972. The infant had developed severe pneumonitis secondary to meconium aspi-ration and was managed on ECMO for three days, allowing her lungs time to heal. Electronic address: robert. In polytrauma patients, cardiovascular shock and pulmonary failure are leading death causes. 2. Some have argued that conducting a RCT of ECMO vs. 2011 Jan;26 (1):5-6. As we read the account of the first neonatal ECMO survivor Esperanza, 1 we wondered whether in 1975, while reading the rejection of his original case report, Dr. P. doi:. Setting 30 countries across five continents, 3 January 2020 to 29 August 2021. Gray BW, El-Sabbagh A, Zakem SJ, Koch KL, Rojas-Pena A, Owens GE, Bocks ML, Rabah R, Bartlett RH, Mychaliska GB. Lynch, Robert H. An excellent summary of ethical considerations for ECMO interventional trials can be found in a 2016 review by Robert Bartlett, MD . Robert Bartlett, MD is considered the founder of ECMO, and the University of Michigan’s ECMO program is the largest in the country. During veno-venous extracorporeal membrane oxygenation (VV-ECMO) support, optimization of oxygenation can be achieved by therapeutic interventions on both patient physiological variables and adjustment of ECMO settings. ECMO was developed by surgeon Dr. Toomasian, R. All of this work helped lead to the extracorporeal membrane oxygenation (ECMO) used today, in which the machine replaces the function of the heart and lung for long periods of time and with less damage than the heart-lung machine. The Extracorporeal Life Support Organization (ELSO) and all of the ELSO worldwide chapters have prepared this document to describe when and how to use extracorporeal membrane oxygenation (ECMO) in COVID-19 patients during this pandemic. He then published articles on the survival of ECMO in neonates and its use increased. This therapy was developed in the USA by Robert H. Ecmo in Pediatric Respiratory Failure Bartlett, Robert H. Introduction to the Labs Overall (above the different labs): Research for ECMO started in the early 1960’s by Dr. Sep 15,. Bartlett, known as the father of ECMO, is credited with painstakingly improving and standardizing the technique, which. Dorson and Larsen’s seminal work coincided with biomedical research by other scientists and practitioners around the country, particularly Robert Bartlett, a physician and medical researcher at the University of Michigan. Dr. Robert Bartlett, Dr. Physiology of Extracorporeal Gas Exchange. However, in 1986 to 1988, 9 of 10 ECMO. Professor, Pediatric Surgery. The great majority of COVID-19 patients (>90%) requiring EC. ELSO webinar, moderated by Dr. Many clinicians were then enthused by the technology and o ered it to their patients. Forbes Global CEO Conference 2023: Key Insights And Highlights. He has contributed the most research regarding ECMO and has built a huge ECMO center, which also runs ELSO and compiles the ELSO Registry. Bartlett MD. Robert Bartlett successfully used ECMO in a newborn following meconium aspiration syndrome to treat lung failure. A Family Guide to Adult ECMO Acknowledgments: Dr. Toomasian, William R. In an ovine model of ARDS due to smoke inhalation and burn injury, early institution of ECCO2R in spontaneously breathing animals was effective in removing CO2 and in reducing PaCO2, but it had no effect on reducing the severity of lung injury or mortality. Alvaro Rojas, Dr. , Michigan Medicine Professor of Surgery Emeritus in General Surgery, the "Father of. ECMO was first used successfully in 1971 by a patient with severe lung. VV ECMO and ECCO 2R techniques. Robert Bartlett. Journals metrics. Robert H Bartlett's 37 research works with 571 citations and 4,591 reads, including: Correction : Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID. M. Gas with a. increases and the number of patients in that arm of the study increases as the study grows. From the Extracorporeal Life Support Program, Department of Surgery, University of Michigan, Ann Arbor, MI. Bio: Dr Robert Bartlett developed extracorporeal life support (ECLS) from the laboratory through the first successful clinical trials to routine practice worldwide. Sign In. The first neonate was saved with extracorporeal membrane oxygenation (ECMO) by Dr. trị bằng ECMO cho tỷ lệ thành công là 80% Zapol WM, Snider MT, Hill JD, et al. Hirschl's phone number, address, insurance information, hospital affiliations and more. Monitoring of AC therapy under ECMO is recommended and the most common parameter used to assess adequacy of AC therapy in ECMO is activated clotting time (ACT) with a goal range between 180-200. As a result of these studies ECLS (also known as extracorporeal membrane oxygenation, ECMO), has been. Coronavirus. Bartlett, MD. Bartlett is known around the world as the Father of ECMO for his pioneering work in the development ECMO. Dr. ECMO provides life support but is not a form of treatment. Jeffrey Punch, Dr. 1995. These guidelines describe useful and safe practice, prepared by ELSO and based on extensive experience and are. He continued to develop the technology, and the use of ECMO gradually increased from a few cases. Der Artikel enthielt ein Foto von ihr, wie sie ihr Diplom von Dr. Robert H. Robert Bartlett, Professor Emeritus, Section of General Surgery, Division of Acute Care Surgery, University of Michigan School of Medicine. He developed this technique when he was. Robert Bartlett Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) has been successful in support of neonates with respiratory failure but requires right common carotid artery ligation. 319-384-5000 or 1-866-890-5969. 1 Additionally, guides detailing the requirements for an ECMO program are available in both the medical literature 2 and the ELSO website. 2022-2024. Joanna J Parga M. Email: [email protected] Our program was established in 1980 by one of the founding fathers of ECMO, Dr. Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure. }, author={Robert H. Important technical factors include venoarterial bypass. Enclosed in this month’s edition of ASAIO Journal, the University of Michigan reports their utilization of extracorporeal membrane oxygenation (ECMO) in more than 2,000 patients over nearly 4 decades. Projects Awarded $3. Bartlett, M. Lynch, Graeme MacLaren, Jay M. 1177/0885066616641383 Abstract Management of gas exchange using extracorporeal membrane oxygenation (ECMO) in respiratory failure is very different than management when the patient is dependent on mechanical ventilation. The primary faculty members supporting the lab are Dr. Carotid arterial access in adults of any age is reasonable. All the gas exchange occurs in the membrane lung, and the arterial oxygenation is the result of mixing the ECMO blood with. Dearborn, Michigan. Ryan P Barbaro 1 , Folafoluwa O Odetola, Kelley M Kidwell, Matthew L Paden, Robert H Bartlett, Matthew M Davis, Gail M Annich. Improvements in devices and materials biocompatibility have made ECLS safer and easier in polytrauma. April 2016. Robert Bartlett, Robert Hooke and more. Beaumont Health, Royal Oak, MI. University of Michigan Ann Arbor, Ann Arbor, MI, United States. He authored "Critical Care Physiology" and " Michigan Critical Caer handbook". O 2 supply is cc. Bartlett et al. 0000000000001223. Robert H. In 1972, Dr. Intensive Care Med. ดร. Robert Bartlett, the trial was “an example of how not to do a trial” because it was too early in the development of ECMO and participating centers did not have enough training to properly execute the recommended ECMO protocol (Bartlett, 2013; unpublished interview). com, Elsevier’s leading platform of peer-reviewed scholarly literature. University of Minnesota, Minneapolis, MN - Cardiothoracic Surgery. Robert Bartlett; Clinicians reserve ECMO for neonates at > 80% predicted mortality risk. Oxygen and. Huxtable and Harry Schippers and. ELSO Foundations Adult ECMO Training Course - Spanish Version 12/21/2021 - 12/01/2028 Location: Online ecmotraining@elso. Extracorporeal membrane oxygenation (ECMO) provides temporary pulmonary and/or cardiac support when medical management fails or when the degree of support required is considered injurious to the patient (1, 2). Affiliation 1 From the ECMO Lab, University of Michigan Medical School,. The use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, although there is controversy regarding the evidence justifying its use (1–9). Journal of Medical Biography 2014 24: 3, 371-376 Download Citation. Robert Bartlett, MD • Surgeon at University of Michigan Medical Center • Developed of ECMO • Treated first infant in 1975 • 26 research grants including $5 Million from Michigan Critical Care Consultants (MCCC). ECMO flow Outlet-Inlet O 2 content (cc/dL) 4 5 6 8 7 Figure 4 The amount of oxygen supplied by a membrane lung is the increase in oxygen content per deciliter of blood times the number of deciliters per minute (the blood flow). Epub 2021 Aug 10. Authors. 1997; 25 (1):28–32. Dr. 66 (8):e113, August 2020. Bartlett, M. Bartlett inspired the audience by describing his role in developing an early membrane. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. Blood is removed from the body of the patient, oxygen is added to the blood, and the blood. Esperanza: The First Neonatal ECMO Patient ASAIO J. Ryan P Barbaro 2 , Samir K Gadepalli 3 , Matthew M Davis 4 , Robert H Bartlett 3 , Folafoluwa O Odetola 2 Affiliations 1 Division of Pediatric Critical Care, Department of Pediatrics, University of Michigan, Ann Arbor, MI. "There are plenty of ECMO machines — it's people who know how to run it," says Dr. George Mychaliska, Dr. Search grants from Robert Bartlett Search grants from University of Michigan Ann Arbor. George Mychaliska, Dr. 2017. Robert H. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. ดร. doi: 10. Newer Post Older Post Home. Robert H. Bartlett is the senior investigator within the laboratory. In its simplest form, ECMO maintains normal DO 2:VO 2Robert Bartlett; The use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, even though. View all special issues and article collections. edu . In the early 1970s, others succeeded with ECMO where Kolobow and Zapol had not; Dr. 1097/MAT. ECMO is one of several terms used for an extracorporeal circuit that directly oxygenates and removes carbon dioxide from the blood ( Figure 1 ). Bartlett and Alan B. Deatrick. Our program was established in 1980 by one of the founding fathers of ECMO, Dr. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. Findings: Data for 1035 patients with COVID-19 who received ECMO support were. Dr. Ogino,. Indice de Capitulos; Capítulo 1: Historia y desarrollo soporte extracorpóreo; Capítulo 2: Fisiología ECLS; Capítulo 3: Insuficiencia Cardiaca: Principios y fisiología; Capítulo 4: Insuficiencia respiratoria hipoxica aguda en niños; Capítulo 5: Interacción entre la sangre y superficie del biomaterial durante ECLS; Capítulo 6: Registro ELSO; Capítulo. While cannulating the femoral artery in VA-ECMO, a distal perfusion catheter needs to be inserted to avoid distal limb ischemia. ECMO was developed by surgeon Dr. Google Scholar R. The infant survived neurologically intact and was adopted following discharge (Figures 1–3). Carotid arterial access scares people, but it is safer than femoral arterial cannulation (personal communication with Dr. Robert H. ECMO support has been evaluated in 29 newborn infants with respiratory failure. Compartimos este video, de la Universidad de Míchigan, en el que se resalta la labor de los profesionales que día a día dedican sus vidas a brindar segundas oportunidades. of treatment. Extracorporeal life support (ECLS) is effective in treating shock status and pulmonary failure. Jeffrey Punch, Dr. Mechanical cardiopulmonary support goes by many names. . Introduction to the Labs Overall (above the different labs): Research for ECMO started in the early 1960’s by Dr. Transport of ECMO patients requires coordination and careful. Bartlett supported a 2 year old boy with VA ECMO after cardiac surgery, and Dr. Robert Bartlett in a basement. (ECMO) technology in 1975. ECMO in the neonatal period was done for the first time by Dr. 1016/S2213-2600(15)00233-7 No. You may opt-out by clicking here. Many aspects of physiology need to be re-learned to use this technology to optimal advantage. F Bartlett 1932 Remembering Frederic C BARTLETT 1886. Bartlett, MD and Joseph B. 14,851 of these cases are patients. 3 days with ECMO. Email: [email protected] Metrics and citationsing complex ECMO transfers, can lead to nosocomial spread and endanger staff safety. Improvements in devices and materials biocompatibility have made ECLS safer and easier in polytrauma. Dr. edu. Robert H Bartlett 1 , Mark T Ogino 2 3 , Daniel Brodie 4 5 , David M McMullan 6 , Roberto Lorusso 7 , Graeme. D. Technology news, shaken not stirred. Bartlett was Director of the Surgical Intensive Care Unit, Program Director of the Surgical. Robert Bartlett and His Lifelong Accomplishments in the Field of Extracorporeal Membrane Oxygenation. VIEW ALL JOURNAL METRICS. B. Zapol, and Robert H. Life-saving ECMO therapy continues to evolve. , Robert Connors, M. PMID:. Author Information . Based on information from the ECRI (a non-profit technology assessment group) evaluation of ECMO, November 1993. Robert Bartlett, Dr. This article was published in Perfusion. View all issues. HE has also published 2 novels. Bartlett* ECLS Laboratory, University of Michigan, B560 MSRB II, 1150 W. Ryan P Barbaro*, Graeme MacLaren*, Philip S Boonstra, Theodore J Iwashyna, Arthur S Slutsky, Eddy Fan, Robert H Bartlett, Joseph E Tonna, Robert Hyslop, Jeffrey J Fanning, Peter T Rycus, Steve J Hyer, Marc M Anders, Cara L Agerstrand, Katarzyna Hryniewicz, Rodrigo Diaz,. 1097/MAT. However, when taking platelet count into consideration, platelet aggregation. Objective: To examine the outcomes of prolonged (≥14 days) extracorporeal membrane oxygenation (P-ECMO) for adult severe respiratory failure and to assess characteristics associated with survival. 7 We report interhospital transport of 5 patients after initiation of venovenous ECMO by our ECMO transport team and subsequent transfer to our hospital for higher level of care with key considerations of PPE use for this transfer and transport-related issues. From the Extracorporeal Life Support Laboratory, Department of Surgery, University of Michigan, Ann Arbor, Michigan VA Ann Arbor Healthcare System, Ann Arbor, Michigan. Alvaro Rojas, Dr. is Professor Emeritus, in the Section of General Surgery, Division of Acute Care Surgery, who continues to be active in the lab and clinical research. Abstract. He is considered to be the rst patient to bene t from the technology.